Comparison of additive effect of omega-3 fatty acid or ezetimibe in combination with statins on the reduction of small dense LDL in patients with coronary artery disease
Phase of Trial: Phase III
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Ezetimibe (Primary) ; Omega-3-fatty-acid (Primary) ; HMG-CoA reductase inhibitors
- Indications Coronary artery disease
- Focus Therapeutic Use
- 06 Jul 2018 Last checked against University Hospital Medical Information Network - Japan.
- 30 Jun 2018 Status changed from recruiting to completed.
- 20 Mar 2013 New trial record